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Abstract
Purpose Measuring quality of life in acute asthmatics is challenging, especially when asthma attacks can occur sporadically. 
Several questionnaires can be used to measure quality of life in this patient group; however, psychometric testing is limited on 
questionnaires that can be used to estimate Quality Adjusted Life years. The objective of this study is to assess the construct 
validity (convergent and discriminative validity) and responsiveness of the EuroQol-5-Dimensions 5-Level (EQ-5D-5L), 
Asthma Quality of Life Utility Index-5 Dimensions (AQL-5D) and Time Trade-Off (TTO) in acute asthma patients.
Methods Data from a prospective cohort study were used to test the validity and responsiveness of the EQ-5D-5L, AQL-
5D and TTO in asthma patients who were recruited from UK accident & emergency departments or hospital wards. The 
spearman’s rank correlation coefficient, the Kruskal–Wallis test statistic and the standardized response mean were used to 
test for convergent validity, discriminative validity and responsiveness, respectively.
Results One hundred and twenty-one participants were included in the available case analysis. The EQ-5D-5L and AQL-
5D showed moderate to strong correlations for convergent validity at baseline, week 4 and week 8. The AQL-5D and TTO 
showed moderate correlations at week 4 and week 8. No statistical significance was observed for discriminative validity at 
baseline. Both the EQ-5D-5L and the AQL-5D also showed that they were sensitive to change for the recovery responses.
Conclusions The EQ-5D-5L and AQL-5D showed stronger construct validity and responsiveness compared to the TTO. 
Therefore, both the EQ-5D-5L and AQL-5D should be considered for use in future economic evaluations.
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Introduction
Patient-reported outcome measures (PROMs) are used 
widely in research as they are useful for capturing patient’s 
perceptions for different health states [1]. The PROMs can 
be disease-specific (particular health-related quality of life 
aspects relating to people with a specific disease or condi-
tion) or generic (particular health-related aspects relating to 
people in general) questionnaires, and they can be conducted 
in different modes and at different time points [2].
As seen in a previous systematic review [3], the use of 
PROMs in asthma is extensive. Many different PROMs 
have been used for asthma studies [3–6], the Asthma Qual-
ity of Life Questionnaire (AQLQ) [7], mini-AQLQ [8], St 
George’s Respiratory Questionnaire (SGRQ) [9] and Euro-
Qol-5-Dimensions (EQ-5D) [10] being some common ones. 
As there are so many different PROMs available to use, it is 
important that there is transparency for their use and knowl-
edge as to which one is more appropriate. However, there 
is no current guidance on the most appropriate PROMs for 
asthma [5].
Testing preference-based measures (measures that 
describe aspects of a patient’s health, which usually consist 
of several domains, the scores from which are converted 
into index scores using an algorithm and typically have a 
scale where 0 is death and 1 is full health) [11] through psy-
chometric techniques have been performed before in many 
different diseases. However, this is limited in asthma where 
reliability, validity and responsiveness are often tested on 
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non-preference-based measures [12–18]. A previous study 
argued that the EQ-5D is valid and reliable for use on asthma 
patients to help clinicians form better decisions [19]. How-
ever, different preference-based measures have not been 
tested for asthma-related crisis events and previous asthma 
studies are often based on the older 3-level (3L) version of 
the EQ-5D, rather than the new 5L version. Therefore, this 
study aims to test the construct validity and responsiveness 
of the EQ-5D-5L [20], AQL-5D [21] and Time Trade-Off 
(TTO) [22] questionnaires. These specific questionnaires 
were chosen because they are preference-based. They are 
based on the responses of a sample of the UK public and 
enable the relative weight of different aspects of quality of 
life (QoL) to be considered such that QoL can be summa-
rized on a 0 (death) to 1 (full health) utility scale.
Methods
Study design and recruitment
This work is based on a prospective observational cohort 
study (Clinical Trials Number: NCT02771678) that recruited 
patients who had an asthma-related crisis event (accident and 
emergency attendance or hospital admission) at one of three 
sites (Norfolk and Norwich University Hospital, University 
Hospital Birmingham and Aberdeen Royal Infirmary) [23]. 
Participants met the inclusion criteria for recruitment if they 
were adults who had an asthma attack, were not hypoxaemic 
and did not need help from a carer to complete the question-
naires. One hundred and twenty-one patients were recruited 
from the hospitals and were asked to complete several qual-
ity of life questionnaires over an 8-week period [23]. All par-
ticipants provided written informed consent, and the study 
was approved by the NHS Cambridge South Research ethics 
committee (REC Reference: 16/EE0023). More details on 
the recruitment, methodology and measures applied in this 
study are reported elsewhere [23].
EuroQol‑5‑Dimensions 5‑Level (EQ‑5D‑5L)
Participants were asked to complete the EQ-5D-5L weekly 
over the 8-week time period. The EQ-5D-5L has questions 
about mobility, self-care, usual activities, pain/discomfort 
and anxiety/depression. Each of these questions has 5 lev-
els to choose from when completing the questionnaire [20]. 
These levels are no problems, slight problems, moderate 
problems, severe problems and extreme problems/unable. 
Once all questions had been answered, then the responses 
were converted into a health utility score on a 0 (death) to 
1 (full health) scale [10]. A visual analogue scale (VAS) is 
also part of the questionnaire and is a scale which ranges 
from 0 (the worst health you can imagine) to 100 (the best 
health you can imagine).
Asthma Quality of Life Utility Index‑5‑Dimensions 
(AQL‑5D)
The AQL-5D is a utility index scale generated from the 
asthma quality of life questionnaire (AQLQ) [7]. Partici-
pants were asked to complete the AQLQ monthly over the 
8-week period. It has 32 asthma-related questions with 
a choice of seven different responses for each question. 
Responses from five questions on the AQLQ were taken 
to generate the AQL-5D on a utility scale of 0 to 1 [21]. 
The responses taken were related to questions around sleep, 
concern, breath, pollution and activity.
Time Trade‑Off (TTO)
The TTO was modified to include two anchor options of 
‘current asthma health state’ and ‘well-controlled asthma’, 
and participants were asked to complete it monthly over the 
8-week period [24]. The ‘well-controlled asthma’ health 
state was described as ‘no asthma symptoms, no limita-
tion of activities due to asthma and no asthma attacks’. This 
modification was undertaken with a view to identify whether 
participants had reached their normal well-controlled asthma 
health state by week 4 or week 8 after having their asthma-
related crisis event, and to estimate the utility loss specifi-
cally associated with an asthma crisis event excluding the 
effect of any comorbidities.
The TTO was initially asked during a face-to-face consul-
tation at baseline using a laptop for visual aid. At the week-4 
and week-8 follow-ups, the TTO was either asked at a face-
to-face consultation during the participant’s routine hospital 
appointment, or over the telephone, if the follow-ups did 
not coincide with the participant’s routine hospital appoint-
ment. Iterative questioning was used for the TTO, starting 
at the mid-point of the participant’s estimated remaining life 
expectancy and increasing or decreasing by 10% increments 
depending on the response of the participant. For example, 
participants were asked whether they would choose their 
‘current asthma’ health state or ‘well-controlled asthma’ 
health state at the mid-point value, and if they chose the 
latter option, their years would decrease by 10% until indif-
ference was achieved. Alternatively, if participants chose the 
‘current asthma’ health state option, then their years would 
increase by 10% until indifference was achieved.
The TTO was chosen as it is the direct valuation method 
that was used for the EQ-5D, at the time of the study’s con-
ception [25]. The modified TTO is used in this study as it 
enabled us to consider whether the individual had returned 
to their well-controlled asthma state, and thereby specifically 
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estimate the loss in utility score associated with an asthma 
crisis event. In contrast, were a patient to have a utility 
score below full health according to the EQ-5D, it would be 
unclear whether they had, e.g. a comorbidity but had fully 
recovered from the asthma event, or instead were still yet 
to recover to their well-controlled asthma state. The use of 
the EQ-5D in the latter situation could lead to the loss in 
utility score associated with an asthma crisis event being 
underestimated.
Construct validity
Construct validity assesses whether the constructs of an 
instrument are measuring what it should be measuring [26]. 
Two forms of construct validity were considered: convergent 
and discriminative validity.
Convergent validity addresses the level of correlation 
between constructs and instruments. It shows whether the 
constructs or instruments that are being compared are related 
to each other as expected. These relations may be strong or 
weak correlations depending on the relationship expected 
between the constructs or instruments compared [27].
The correlations for convergent validity have been 
assessed at baseline, week 4 and week 8 of the study. The 
Spearman’s rank correlation coefficient was used to deter-
mine the correlations with statistical significance considered 
at the 5% level. Additionally, correlations were considered 
weak if < 0.3, moderate if 0.3 to 0.5 and strong if > 0.5 [28].
Discriminative validity (also known as known-group 
validity) is another type of construct validity which has been 
considered in this analysis [27]. When groups are expected 
to differ between each other, a test can be conducted to 
help assess whether a measure can discriminate between 
the groups. The analysis was conducted based on specific 
groups that were anticipated to have different levels of util-
ity at baseline due to their different asthma severity. Three 
peak expiratory flow (PEF) groups were chosen to conduct 
this analysis, where the PEF was recorded by medical report 
using a PEF meter [29]:
• < 50% of the best/predicted PEF (life threatening or acute 
severe asthma)
• 50–75% of the best/predicted PEF (moderate acute 
asthma)
• > 75% of the best/predicted PEF (good/very good 
asthma)
The Kruskal–Wallis test statistic was used to conduct the 
test for discriminative validity across the instruments using 
the above three PEF subgroups, i.e. to test for a significant 
difference in mean rank scores between groups. p-values 
were used to display the statistical significance.
Responsiveness
This was an assessment of all of the quality of life question-
naires, including the PEF to detect any sensitivity to change 
[26]. The idea behind responsiveness is that it should high-
light whether the instruments are measuring the constructs 
as it should, e.g. by detecting whether an expected improve-
ment or deterioration over a period of time is reflected in 
the scores for that instrument. Accordingly, we compared 
groups based on the following question which was asked at 
week 4 of the study:
Question Compared to your asthma state when you were 
in hospital approximately 4 weeks ago, how would you 
rate your asthma now?
Answers options very good, good, moderate, poor or very 
poor.
Responses to the above question were grouped into 4 cat-
egories. As none of the participants chose the last item, ‘very 
poor’, this category was omitted from the groups. Wilcoxon 
signed-rank tests were conducted to identify any significant 
changes in scores within each category, accompanied with 
effect size (ES) and standard response mean (SRM) calcula-
tions [27].
The SRM helped to indicate how responsive the ques-
tionnaires were to change where a higher value would be 
expected for asthmatics who rated their asthma state as very 
good compared to 4 weeks ago. Values ranging between 0.20 
and 0.50 were considered small, 0.50 to 0.80 were consid-
ered moderate and greater than 0.80 were considered large 
[30].
Results
The available case analysis was used for this study, where 
121 participants were recruited, 42 were lost to follow-up 
and 8 withdrew [23]. Table 1 shows the baseline partici-
pant characteristics of the available case analysis. The par-
ticipants were recruited from three hospital sites in the UK 
(Norwich, Birmingham and Aberdeen) in 1 year, which 
increased the generalizability of the study [23]. The sam-
ple size, participant characteristics and attrition rate are 
similar to other asthma studies which assess the validity of 
PROMs, which further confirms the representativeness and 
Effect size (ES) ∶
Mean change
Standard deviation at baseline
Standardised Response Mean (SRM) ∶
Mean change
Standard deviation of change
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generalizability of the data [31, 32]. As a sensitivity analy-
sis, a complete case analysis (participants who completed all 
measures, at all three time points, N = 44) was undertaken, 
where it can be seen they had similar characteristics to the 
available case sample (see Supplementary Table 1).
Convergent validity
The convergent validity for baseline, week 4 and week 8 
is shown in Tables 2, 3 and 4, respectively, using Spear-
man’s rank correlation coefficients for the preference-based 
measures.
At baseline, the relationship between the EQ-5D-5L and 
the AQL-5D were significant at the 1% level, whilst the EQ-
5D-5L and the TTO, and the AQL-5D and the TTO were not 
significantly correlated.
The convergent validity relationships highlighted at 
baseline had become stronger at week 4. The EQ-5D-5L 
and the AQL-5D improved to have a strong correla-
tion at the 1% level. The AQL-5D and the TTO had a 
better relationship at week 4, with a moderate correlation 
observed at the 5% level.
The same relationships were also observed for the con-
vergent validity at week 8 of the study, as compared to 
the convergent validity relationships observed at week 4 
of the study. Both the EQ-5D-5L and the AQL-5D, and 
the AQL-5D and the TTO showed the same relationship.
Discriminative validity
Table 5 shows the discriminative validity test based on 
three PEF groups. The PEF groups were split into catego-
ries of different asthma severities: < 50% of best/predicted 
PEF, 50–75% of best/predicted PEF and > 75% of best/
predicted PEF [29]. The lower proportion (< 50% of best/
predicted PEF) indicates that the participants are furthest 
away from their best or predicated PEF, indicating that 
they are more poor (have life threatening asthma or acute 
severe asthma) than the participants who have a PEF of 
> 75% of their best or predicted PEF (good or very good 
asthma).
Most of the participants were within the 50–75% of 
best/predicted PEF category indicating that they had mod-
erate acute asthma at baseline. Interestingly, at baseline, 
some participants were in the third PEF category which 
indicated they had good/very good asthma based on their 
PEF being > 75% of their best/predicted value. Even 
though, most of the mean rank utility values were increas-
ing as hypothesized from the lowest PEF group (< 50% of 
best/predicted PEF) to the highest PEF group (> 75% of 
best/predicted PEF), the change was not very large and 
the results showed no statistical significant differences 
between any of the preference-based measures displayed.
Table 1  Baseline characteristics of participants for available case 
analysis
Demographics N = 121
Age (mean, years) 49.68
Height (mean, cm) 167.22
Weight (mean, kg) 85.54
Gender (%)
 Male 26.45
 Female 73.55
Ethnicity (%)
 White 95.83
 Mixed white and black 0.83
 White other 3.33
Smoking status (%)
 Never 42.50
 Non smoker 1.67
 Smoker 15.00
 Ex-smoker 40.83
Highest level of education (%)
 School 47.06
 College 33.61
 Degree 19.33
Employment status (%)
 Full-time 27.50
 Part-time 15.83
 Retired 28.33
 Stay at home parents 7.50
 Student 3.33
 Unemployed 17.50
Table 2  Convergent validity at baseline using Spearman’s rank cor-
relation coefficient
**p value is < 0.01 therefore statistically significant at the 1% level
a Pairwise correlation coefficients displayed. Correlation coefficients 
considered < 0.3 are weak, 0.3 to 0.5 are moderate and > 0.5 are 
strong
EQ-5D-5L  
(utility)
AQL-5D  
(utility)
TTO  
(utility)
EQ-5D-5L (utility) N = 120
1.0000a
AQL-5D (utility) N = 118 N = 118
0.3888a** 1.0000a
TTO (utility) N = 111 N = 109 N = 112
0.1287a 0.0864a 1.000a
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Responsiveness
The responsiveness test was conducted and observed how 
participants felt at week 4 of the study compared to how they 
were at baseline when in hospital with their asthma-related 
crisis event. Table 6 shows the results of the changes in 
means between baseline and week 4. As hypothesized, most 
of the utilities demonstrated sensitivity to change (which is 
highlighted from the SRM values). The range for the mean 
change from poor to very good groups in the EQ-5D-5L 
utility was from − 0.276 to 0.175, for the AQL-5D from 
− 0.0065 to 0.169 and for the TTO from − 0.173 to 0.254. 
The TTO was the only preference-based measure which 
didn’t have a large sensitivity to change in any of the four 
groups (poor, moderate, good and very good). Conversely, 
the AQL-5D showed large responsiveness to change for the 
very good and good group, and the EQ-5D-5L showed large 
responsiveness for the good and poor groups.
Discussion
This study used psychometric techniques to analyse the 
construct validity and responsiveness relationships between 
preference-based measures for people with acute asthma. 
The data used for this analysis was the available case analysis 
from the prospective cohort data collected from across three 
hospital sites in the UK from when people attended A&E 
or were admitted to hospital with acute asthma symptoms. 
This study analysed the observed findings by comparing the 
Table 3  Convergent validity at 
week 4 using Spearman’s rank 
correlation coefficient
*p-value is < 0.05, **p-value is < 0.01 therefore statistically significant at the 5% level and 1% level, 
respectively
a Pairwise correlation coefficients displayed. Correlation coefficients considered < 0.3 are weak, 0.3 to 0.5 
are moderate and > 0.5 are strong
EQ-5D-5L (utility) AQL-5D (utility) TTO (utility) PEF
EQ-5D-5L (utility) N = 71
1.0000a
AQL-5D (utility) N = 63 N = 70
0.5355a** 1.0000a
TTO (utility) N = 62 N = 62 N = 87
0.1771a 0.3027a* 1.000a
Table 4  Convergent validity at week 8 using Spearman’s rank corre-
lation coefficient
*p-value is < 0.05, **p-value is < 0.01 therefore statistically signifi-
cant at the 5% level and 1% level, respectively
a Pairwise correlation coefficients displayed. Correlation coefficients 
considered < 0.3 are weak, 0.3 to 0.5 are moderate and > 0.5 are 
strong
EQ-5D-5L (util-
ity)
AQL-5D (util-
ity)
TTO (utility)
EQ-5D-5L (util-
ity)
N = 64
1.0000a
AQL-5D (util-
ity)
N = 61 N = 64
0.6260a** 1.0000a
TTO (utility) N = 60 N = 58 N = 80
0.1871a 0.3087a* 1.000a
Table 5  Discriminative (known-group) validity at baseline using 
three PEF subgroups (aKruskal–Wallis test conducted and PEF split 
into three subgroups: < 50% of PEF best/predicted = life threaten-
ing/acute severe asthma; 50–75% of PEF best/predicted = moderate 
acute asthma and > 75% of best/predicted asthma for good/very good 
asthma [29]) against preference-based measures
*No statistical significant difference found for all PROMs between the three PEF subgroups
a Mean rank: The utilities are ranked from lowest to highest, and an average is taken based on the ranked order of utilities. The group with the 
lowest mean rank have the greatest number of lower utility values, and the group with the highest mean rank have the greatest number of higher 
utility values
< 50% of best/
predicted PEF 
mean  ranka
< 50% of best/
predicted PEF 
N
50–75% of best/
predicted PEF 
mean  ranka
50–75% of 
best/predicted 
PEF N
> 75% of best/
predicted PEF 
mean  ranka
> 75% of best/
predicted PEF 
N
p-value*
EQ-5D-5L utility 53.64 18 57.02 42 71.89 27 0.105
AQL-5D utility 53.36 18 56.45 42 68.96 26 0.223
TTO utility 49.91 16 58.11 40 56.70 28 0.713
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preference-based measures at three main time points during 
the study, which were baseline, week 4 and week 8.
Summary of findings
The correlations between the preference-based measures 
were mostly moderately to strongly correlated and had 
strengthened from time points at baseline, through to week 
4 and week 8. At baseline, the EQ-5D-5L and the AQL-5D 
were significantly correlated at the 1% level. As the study 
progressed, the TTO and AQL-5D also showed more of an 
association, reaching statistical significance at the 5% level 
at week 4 and week 8 of the study, suggesting that the TTO 
and AQL-5D were correlating better when the participants 
were nearer to their recovery from their asthma-related crisis 
event.
The discriminative validity comparing the three PEF 
groups with the EQ-5D-5L, AQL-5D and TTO showed no 
statistical significant differences across the groups, even 
though the mean rank scores generally increased as PEF 
severity reduced.
A sensitivity analysis using complete cases (participants 
completing all measures, at all time points) was also under-
taken (see Supplementary Material Tables 1 to 6), where the 
results can be seen to be broadly comparable to that of the 
available case analysis.
Comparison with other studies
We found the correlation coefficients between the TTO and 
the EQ-5D-5L were much weaker compared to the EQ-5D-5L 
and the AQL-5D. Even as the study progressed, they stayed 
weak with no statistical significance. A previous asthma-
related cross-sectional study compared the TTO with the 
EQ-5D but had a higher correlation coefficient of 0.40, indi-
cating a moderate correlation [33]. However, there were sev-
eral differences between that study [33] and this current study 
around the participant population group, the questioning of 
the TTO and the number of levels on the EQ-5D. Neverthe-
less, in both studies, the TTO correlations had lower correla-
tions compared to the other preference-based measures, which 
suggests the TTO is less suitable in asthma populations.
The discriminative test indicated that the preference-
based measures were not very good at discriminating 
between the three PEF groups. Possible explanations for this 
result are that the preference-based measures are not able to 
capture changes related to the PEF, or that such PEF changes 
do not constitute a notable score change on the utility scale.
When assessing the responsiveness test conducted in this 
study (using the recovery questions from the participants at 
week 4 of the study), the AQL-5D and the EQ-5D-5L had 
larger responsiveness compared to the TTO. As the AQL-
5D is derived from the AQLQ and has been also shown to 
Table 6  Responsiveness of all preference-based measures between baseline and week 4 for recovery rates
ES effect size (mean change/SD at baseline)
*Small change, small responsiveness
**Moderate change, moderately responsive
***Large change, largely responsive
a Wilcoxon signed-rank test conducted and p-values in bold are statistically significant at the 5% level
b SRM standardized response mean (mean change/SD of change). If SRM = 0.2 to 0.50 equals small, 0.50 to 0.80 equals moderate and 0.80 and 
above equals large
Items N Baseline (mean) Week 4 (mean) Mean change SD at baseline SD at change ES SRMb p  valuea
EQ-5D-5L
 Very good 14 0.747 0.922 0.175 0.280 0.235 0.625 0.745** 0.011
 Good 17 0.585 0.807 0.221 0.325 0.233 0.680 0.948*** 0.000
 Moderate 24 0.630 0.724 0.094 0.265 0.239 0.355 0.393* 0.031
 Poor 8 0.604 0.328 − 0.276 0.148 0.268 − 1.865 − 1.030*** 0.066
AQL-5D
 Very good 15 0.629 0.798 0.169 0.135 0.187 1.252 0.904*** 0.010
 Good 17 0.621 0.787 0.166 0.132 0.140 1.258 1.186*** 0.001
 Moderate 26 0.560 0.621 0.061 0.113 0.110 0.540 0.555** 0.023
 Poor 9 0.529 0.524 − 0.005 0.107 0.019 − 0.047 − 0.263* 0.356
TTO
 Very good 14 0.679 0.932 0.254 0.250 0.329 1.016 0.772** 0.014
 Good 19 0.682 0.908 0.227 0.296 0.320 0.767 0.709** 0.013
 Moderate 23 0.598 0.787 0.189 0.297 0.348 0.636 0.543** 0.008
 Poor 8 0.881 0.708 − 0.173 0.177 0.376 − 0.977 − 0.471* 0.468
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have strong correlations in this study and others [21], this 
supports the use of the AQL-5D.
Strengths and limitations
The use of three different PROMs in this study is a strength 
for the comparison of psychometric techniques. Despite this, 
only construct validity and responsiveness were assessed in 
this study, which is a limitation, as there are other psycho-
metrics techniques which are useful for comparing meas-
ures. Secondly, the sample size was small when testing for 
discriminant validity and responsiveness, particularly due to 
the response rates. Therefore, it is recognized that a larger 
sample size would encourage more robust and representative 
results between groups.
Recommendation for the future
In the light of the findings from this study, both the construct 
validity and responsiveness tests suggest which preference-
based measures should be considered for the acute asthma 
population group for the criteria assessed. Overall, given the 
TTO performed poorly on the validity and responsiveness 
tests, we consider the AQL-5D and the EQ-5D-5L for use in 
economic evaluations for asthma studies. Even though the 
AQL-5D is a recent development [34], previous literature 
and this current study have strongly confirmed its perfor-
mance [21, 35]. Therefore, it is suggested that the disease-
specific questionnaire, AQLQ, is used in asthma studies 
in order to estimate utilities using the AQL-5D. However, 
given that NICE has recommended using the EQ-5D in eco-
nomic evaluations [36, 37], this should still be considered.
Conclusion
In conclusion, this study aimed to compare the performance 
between three preference-based measures that were used in 
a prospective cohort study, which estimated the loss asso-
ciated with an asthma-related crisis event. Psychometric 
techniques, in particular, convergent validity, discriminative 
validity and responsiveness, were used in this analysis. In 
this study, out of the three outcome measures tested, we do 
not consider the TTO to be the most appropriate measure in 
this population given it performs poorly on tests of construct 
validity and responsiveness. Instead, we suggest the AQL-
5D and EQ-5D-5L should be considered.
The EQ-5D-5L and the AQL-5D illustrated moderate 
to strong correlations throughout all three time points at 
baseline, week 4 and week 8. Small to large changes were 
observed in the preference-based measures for the level of 
sensitivity to change for the recovery groups. However, 
the discriminative test indicated that the preference-based 
measures were not very good at discriminating against the 
three PEF groups, and the TTO showed weak correlations 
between the EQ-5D-5L and the AQL-5D.
Therefore, the results overall highlight that the EQ-5D-5L 
and AQL-5D are well correlated and sensitive to change for 
participants who have had an asthma-related crisis event. For 
the purposes of economic evaluation studies, and the fact 
that previous research recommends the use of the EQ-5D, 
both the EQ-5D-5L and the AQL-5D should be considered 
in the future. Nevertheless, it is important to bear in mind 
that both of these questionnaires have been recently devel-
oped, and therefore, further research is encouraged on a 
larger, more complete data set.
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